SOMERSET, N.J., Jan. 31 /PRNewswire-FirstCall/ -- Ventiv Health Inc. announced today that various members of its management team will present at relevant investor conferences during February 2006.
NASDAQ International Small Cap Conference Merrill Lynch Financial Centre February 7-8, 2006 London, U.K.
Held in London, the largest investment center outside of the U.S., NASDAQ is providing NASDAQ-listed companies with a neutral and interactive forum to present to over 90% of the entire European institutional investment community investing in U.S. equities. Ventiv will join ten NASDAQ-listed companies in the healthcare and consumer areas for a day of group presentations and one-on-one meetings.
Eran Broshy, Chief Executive Officer of Ventiv and Bill O’Donnell, Chief Financial Officer of Ventiv’s Communications division will attend the event and present the Ventiv investment story.
Ventiv’s presentation will take place Wednesday, February 8 at 2:00 p.m. UBS Global Healthcare Services Conference Grand Hyatt New York February 13-15, 2006 New York, New York
Eran Broshy and John Emery, Ventiv’s Chief Financial Officer will present on behalf of Ventiv. For more information on the agenda for the conference, please visit http://www.ubs.com.
Ventiv’s presentation will take place Tuesday, February 14 at 11:30 a.m. Roth Capital Partners 18th Annual OC Conference St. Regis Monarch Beach Resort and Spa February 20-22, 2006 Dana Point, California
Roth Capital will feature presentations from over 250 small-cap companies across a broad spectrum of sectors, such as technology, healthcare, financial services and consumer products.
John Emery, Ventiv’s Chief Financial Officer will make the corporate presentation on behalf of Ventiv on February 21 at 4:00 p.m.
Audio webcasts will be available for all conferences and accessible by visiting the Ventiv website at http://www.ventiv.com.
About Ventiv Health
Ventiv Health, Inc. is the leading provider of commercialization services to the global pharmaceutical and lifesciences industries. Ventiv delivers its customized clinical, sales, marketing and communications services through its three core business segments: Commercial Services, Clinical Services and Communications Services. Ventiv’s 4,600 employees support over 150 client organizations, including 18 of the Top 20 global pharmaceutical companies as well as emerging and specialty biotech leaders. For more information on Ventiv Health, Inc. visit http://www.ventiv.com.
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks that may cause Ventiv Health’s performance to differ materially. Such risks include, without limitation: changes in trends in the pharmaceutical industry or in pharmaceutical outsourcing; our ability to compete successfully with other services in the market; our ability to maintain large client contracts or to enter into new contracts; uncertainties related to future incentive payments and revenue share agreements; and, our ability to operate successfully in new lines of business. Readers of this press release are referred to documents filed from time to time by Ventiv Health, Inc. with the Securities and Exchange Commission for further discussion of these and other factors.
Ventiv Health Inc.
CONTACT: Investors/Corporate - John Emery, CFO, +1-732-537-4804,investor@ventiv.com, or Media - Felicia Vonella, +1-212-308-7155,fvonella@ventiv.com, both of Ventiv Health, Inc.
